Fritextsökning
Innehållstyper
-
International models among science parks
Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...
-
Lytix calls in cash
Norwegian company Lytix Biopharma closes a USD 1.4 million funding round to finance new antimicrobial and oncology lead compounds.
-
Medicult disclaims Swedish offer
The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Hormones make children fat
A new Danish million project will define the connection between hormons and obesity amongst children.
-
Collaboration brings next generation drugs
Wyeth and Santaris Pharma announce a new alliance to develop RNA-based medicines.
-
375 miljoner till cancerforskare
Cancerfonden ger Ruth Palmer pengar för forskning på signalöverföring och ett av de största anslagen går till forskning om genexpression. Även projekt inom blan...
-
Så vill branschen rädda branschen
Sweden Bio, Lif och Swedish Medtech presenterar i dag en plan på hur life science-branschen i Sverige ska räddas.
-
Early stage research and low turnaround dominates
Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...
-
Test if you carry the fat virus
In a soon future there may be a quick and simple test that could show if you are infected with Ad-36, a human adenovirus that can make you over-weight.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
Vitamin D is mental health aid
Vitamin D can help stave off the mental decline that can affect people in old age, a study suggests.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
820 miljoner till medicinsk forskning
359 projekt inom området för medicin får pengar från Vetenskapsrådet i år. I snitt kammar varje projekt hem 670 000 kronor i årets runda.
-
Algoritmer i stället för provrör
Mitt i Stockholm city jobbar drygt 70 personer med att ta fram och förfina mjukvaran till dosplaneringssystemet Raystation för strålterapi mot cancer.
-
Ambassador program makes MVA big in Japan
The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a signifi...
-
”Ny antibiotika kräver ny modell”
”Vi vill att det ska finnas antibiotika för alla infektioner, men samtidigt vill vi att de används så lite som möjligt”, säger John H Rex vid Astrazenecas affär...
-
Lundbeck divests companies
The company sells all shares in one listed company plus divests four small private equity funds, for a three-figured million sum.
-
Diagnostics for personalized medicine
Per Matsson from Phadia anticipates changes in the standards for health care. Accordiing to him, expensive new drugs will create a market for more extensive diagnostics.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Ideon - Sweden's oldest science park
Old is not synonymous with boring. Swedens oldest science park Ideon still manages to attract young companies with big ideas. The recipe for success? To continu...
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...
-
Mingling types - who to aim for and who to avoid:
Read about different mingling types - who are you?
-
Hon utvecklar teknik för hälsodata
E-hälsa är inte i stället för vård. Det är en möjlighet att ta ansvar för att den medicin som man äter ska göra mest möjliga nytta. Det menar forskaren Sara Rig...